Concepedia

Publication | Open Access

A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis

DOIFull Paper Access

32

Citations

31

References

2010

Year

Elliot M. Frohman, Gary Cutter, Gina Remington, Hongjiang Gao, Howard Rossman, Bianca Weinstock‐Guttman, Jacqueline Durfee, Amy Conger, Ellen Carl, Katherine Treadaway,
Therapeutic Advances in Neurological Disorders

Abstract

The results from this pilot study suggest that the application of MMF monotherapy in MS deserves further exploration.

References

YearCitations

Page 1